1 in 5 Will Face Cancer And Oncology Is Shifting The Statistics

In 2022, the world faced the harsh reality of cancer, with 20 million new cases and 9.7 million lives lost to the disease. With over 53.5 million people living within five years of a diagnosis, cancer's impact is felt by nearly everyone, as 1 in 5 people will develop it in their lifetime.

Oncology Ventures is where hope and science meet, offering a lifeline to millions. Every new discovery in this field isn't just about technology—it's about giving patients and their families a fighting chance.

Oncology, led by seasoned healthcare investor Ben Freeberg, has announced the successful close of its oversubscribed $30 million Fund I. This fund is laser-focused on investing in data-driven startups that aim to transform cancer care and research, making it more affordable, efficient, and accessible for patients and their families.

Ben Freeberg's journey to launching Oncology Ventures is deeply personal and shaped by his own battle with cancer. Six and a half years ago, while working as an associate at Alpha Partners, Freeberg experienced a sudden health scare that doctors initially dismissed. It wasn't until nearly a year later that he was diagnosed with Stage 3a cancer, a discovery that came too late to prevent multiple surgeries and a grueling chemotherapy regimen. This harrowing experience ignited a passion in Freeberg to make a difference in the oncology space, leading him to leverage his extensive background in healthcare investment to create a fund dedicated to improving cancer care.